FDA Labeling Status of Pediatric Medications

Abstract

Get full access to this article

View all access options for this article.

References

Wilson JT . An update on the therapeutic orphan. Pediatrics. 1999;104 (Suppl):585-590.

Blumer JL . Off-label uses of drugs in children. Pediatrics. 1999;104(Suppl):598-602.

Committee on Drugs , American Academy of Pediatrics . Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics. 1995;95:286-294.

Steinbrook R . Testing medications in children. N Engl J Med. 2002;347:1462-1470.

Committee on Drugs , American Academy of Pediatrics . Unapproved uses of approved drugs: the physician, the package insert and the Food and Drug Administration: subject review. Pediatrics. 1996;98:143-145.

Meadows M . Drug research and children. Available at: http://www.fda.gov/fdac/features/2003/103_drugs.html. Accessed on September 11, 2003.

Thomson Micromedex Healthcare Series, Volume 121. Available at: http://micromedex.med.umich.edu/mdxcgi/mdxhtml.exe?&tmpl=mdxhome.tm1&SCRNAME=mdxhome&CTL=E:%5Cmdx%5Cmdxcgi%5Cmegat.sys. Accessed on November 12, 2004.

Roberts R , Rodriguez W , Murphy D , Crescenzi T . Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 2003;290:905-911.